Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-07T19:33:43.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-04-30T14:20:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T12:26:51.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new identifiers and collaborators related to a clinical trial for B-cell non-Hodgkin lymphoma, while significant details about the trial's methodology and inclusion criteria have been removed.
    Difference
    47%
    Check dated 2025-04-16T10:09:11.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 31, 2024.
    Difference
    0.7%
    Check dated 2025-04-09T04:56:22.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The term 'B-cell Lymphoma' has been added to the page, while 'Lymphosarcoma' has been removed.
    Difference
    0.2%
    Check dated 2025-04-01T22:12:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.